Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
Public ClinicalTrials.gov record NCT04991116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Extension Study to Evaluate Long Term Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
An open label phase 3 study
Study identification
- NCT ID
- NCT04991116
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 529 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2022 (Actual)
- Primary completion
- Dec 2028 (Estimated)
- Completion
- Apr 2029 (Estimated)
- Last update posted
- Mar 5, 2026
2022 – 2029
United States locations
- U.S. sites
- 41
- U.S. states
- 18
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sunpharma site no 50 | Dothan | Alabama | 36305 | — |
| Sunpharma site no 80 | Gilbert | Arizona | 85297 | — |
| Sunpharma site no 65 | Mesa | Arizona | 85210 | — |
| Sunpharma site no 105 | Phoenix | Arizona | 85032 | — |
| Sunpharma site no. 30 | Covina | California | 91722 | — |
| Sunpharma site no 110 | Encino | California | 91436 | — |
| Sunpharma site no. 17 | Fountain Valley | California | 92708 | — |
| Sunpharma site no. 15 | Thousand Oaks | California | 91320 | — |
| Sunpharma site no 113 | Avon Park | Florida | 33825 | — |
| Sunpharma site no. 21 | Clearwater | Florida | 33765 | — |
| Sunpharma site no. 02 | Hialeah | Florida | 33016 | — |
| Sunpharma site no 71 | Kissimmee | Florida | 34744 | — |
| Sunpharma site no 107 | Margate | Florida | 33063 | — |
| Sunpharma site no. 05 | New Port Richey | Florida | 34652 | — |
| Sunpharma site no 32 | Ocoee | Florida | 34751 | — |
| SunPharma Site no 22 | Tamarac | Florida | 33321 | — |
| Sunpharma site no 52 | Gainesville | Georgia | 30501 | — |
| Sunpharma site no 51 | Orland Park | Illinois | 60467 | — |
| Sunpharma site no 49 | Schaumburg | Illinois | 60195 | — |
| Sunpharma site no 47 | Skokie | Illinois | 60076 | — |
| Sunpharma site no. 20 | Wichita | Kansas | 67207 | — |
| Sunpharma site no. 14 | Springfield | Missouri | 65807 | — |
| Sunpharma site no 104 | St Louis | Missouri | 63119 | — |
| Sunpharma site no 48 | Kalispell | Montana | 59901 | — |
| Sunpharma Site no 27 | Lincoln | Nebraska | 68516 | — |
| Sunpharma site no 33 | Voorhees Township | New Jersey | 08043 | — |
| Sunpharma site no 34 | Charlotte | North Carolina | 28204 | — |
| Sunpharma site no 111 | Leland | North Carolina | 28451 | — |
| Sunpharma site no 53 | Wilmington | North Carolina | 28401 | — |
| Sunpharma site no 35 | Minot | North Dakota | 58701 | — |
| Sunpharma site no. 11 | Middleburg Heights | Ohio | 44130 | — |
| Sunpharma site no 31 | Greenville | South Carolina | 29601 | — |
| Sunpharma site no. 08 | Baytown | Texas | 77521 | — |
| Sunpharma site no. 13 | Baytown | Texas | 77521 | — |
| Sunpharma Site no 28 | Lubbock | Texas | 79410 | — |
| Sunpharma site no 109 | Mesquite | Texas | 75150 | — |
| Sunpharma site no. 03 | San Antonio | Texas | 78229 | — |
| Sunpharma site no. 16 | San Antonio | Texas | 78229 | — |
| Sunpharma site no. 01 | Tomball | Texas | 77375 | — |
| Sunpharma site no 96 | Salt Lake City | Utah | 84132 | — |
| Sunpharma site no 66 | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04991116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04991116 live on ClinicalTrials.gov.